Endothelium-derived NO is considered to be primarily an important determinant of vascular tone and platelet activity; however, the modulation of myocardial metabolism by NO may be one of its most important roles. This modulation may be critical for the regulation of tissue metabolism. Several physiological processes act in concert to make endothelial NO synthase-derived NO potentially important in the regulation of mitochondrial respiration in cardiac tissue, including (1) the nature of the capillary network in the myocardium, (2) the diffusion distance for NO, (3) the low toxicity of NO at physiological (nanomolar) concentrations, (4) the fact that low PO 2 in tissue facilitates the action of NO on cytochrome oxidase, and (5) the formation of oxygen free radicals. A decrease in NO production is involved in the pathophysiological modifications that occur in heart failure and diabetes, disease states associated with altered cardiac metabolism that contributes to the evolution of the disease process. In contrast, several drugs (eg, angiotensin-converting enzyme inhibitors, amlodipine, and statins) can restore or maintain endogenous production of NO by endothelial cells, and this mechanism may explain part of their therapeutic efficiency. Thus, the purpose of this review is to critically evaluate the role of NO in the control of mitochondrial respiration, with special emphasis on its effect on cardiac metabolism.
S ince the discovery of the endothelial dependence of acetylcholine-induced vasorelaxation in vitro by Furchgott and Zawadzki, 1 NO has been identified as the prototypic endothelium-derived relaxing factor. NO is synthesized from the amino acid L-arginine by a family of enzymes, the NO synthases (NOSs) . NO synthesized by the endothelium of small vessels is involved in the control of vascular tone and plays an important role in the regulation of blood pressure. [2] [3] [4] [5] [6] Shear stress acting on the endothelial lining of blood vessels is believed to be the most important physiological stimulus for the release of NO. 7 Studies have demonstrated the presence of endothelial NOS (eNOS) enzyme in and the production of NO by all of the vessels of the coronary circulation. 8, 9 NO has the ability to dilate large vessels 10, 11 and is likely to have a role in the control of capillary perfusion pressure and filtration ( Figure 1 ). Metabolism (ie, O 2 consumption and substrate utilization) is the main determinant of organ function and is therefore an important determinant of blood flow. 12 The increase in blood flow during exercise, to active skeletal muscle and the heart, increases O 2 delivery and at the same time shear stress, and consequently NO release. However, several studies have shown that blockade of NO synthesis has little or no effect on changes in coronary blood flow in conscious dogs during acute exercise. 13, 14 Since the discovery of another major role of NO, ie, a direct effect on the regulation of mitochondrial respiration, an alternative explanation for this discrepancy has been provided. [15] [16] [17] [18] The present review will focus on the role of NO in the regulation of O 2 consumption in vivo and in vitro. The modulation of O 2 consumption depends on the interaction of NO and O 2 , their respective diffusion distances, and their common binding site on cytochrome oxidase ( Figure 2 ). The physiological and pathophysiological consequences of this regulation and therapeutic implications will be discussed.
Role of NO in the Regulation of Oxygen Consumption
The discovery by Hibbs and colleagues of the biological synthesis of NO by activated macrophages provided the conceptual underpinnings for the regulation of O 2 consumption by NO in the myocardium. While examining mechanisms by which cytotoxin-activated macrophages produce cytostasis during cocultivation with neoplastic cells, Granger et al 19 showed that mitochondrial energy metabolism (and DNA synthesis) was severely inhibited in tumor cells. These experiments demonstrated that the inhibition of neoplastic cell growth was associated with a depression in O 2 consumption. Granger and Lehninger 20 showed that the reduction in respiration in this model was caused by the inhibition of complex I (NADH-ubiquinone oxidoreductase) and complex II (succinate-ubiquinone oxidoreductase) of the mitochondrial electron transport chain. The cytotoxic mechanism was associated with the loss of intracellular iron. 21 This would explain the inhibition of these enzymes that require Fe for their catalytic function. In addition, cytotoxin-activated macrophages caused rapid inhibition of mitochondrial aconitase in tumor cells. 22 These mechanisms were dependent on extracellular L-arginine, which was converted to L-citrulline during this process, 23 and the effects of macrophage-induced toxicity were inhibited by N G -monomethyl-L-arginine. 24 Finally in 1989, Hibbs et al 25 identified NO as the effector molecule of this cytotoxicity. They showed that NO was synthesized from L-arginine by activated macrophages and that NO gas induced the same pattern of toxicity and inhibition of mitochondrial respiration. N G -monomethyl-Larginine specifically inhibited this toxicity. As iron-sulfur centers of proteins are sensitive targets for formation of Fe-NO complexes, their results suggested that L-argininedependent cytoxocity was related to the interaction of NO with the iron-sulfur center of the enzymes. 26 Stuehr and Nathan 27 reported similar effects of NO in cytostasis and respiratory inhibition in tumor target cells. Their work clearly demonstrated the synthesis of NO in eukaryotes and the importance of L-arginine metabolism in the regulation of mitochondrial respiration. In the aforementioned studies, the pathway leading to the production of NO was not constitutive; nevertheless, the data clearly defined the mechanism for the physiological regulation of mitochondrial respiration by NO.
Work on the L-arginine dependence of macrophage cytotoxicity for tumor cells was extended to defense against microorganisms and demonstrated the importance of L-arginine as a substrate to inhibit replication (Cryptococcus neoformans). A strong correlation was also shown between macrophage fungistasis and production of nitrite/nitrates. The effect of L-arginine was concentration dependent, and fungistasis was specifically inhibited by N G -monomethyl-Larginine. 28, 29 In a model of Leishmania major-infected macrophages, NO appears to produce iron efflux, which could result in inhibition of Fe-dependent enzymes. 30 Furthermore, the production of cytokine-induced NO is associated with increase in resistance of cultured murine cells to other pathogens, such as Toxoplasma, Mycobacterium leprae, M. tuberculosis, and Plasmodium. [31] [32] [33] [34] Brown and Cooper 35 in 1994 demonstrated that nanomolar concentrations of NO, ie, physiological concentrations as would be released by eNOS, directly and rapidly inhibited isolated cytochrome oxidase. The inhibitory concentration of NO for cytochrome oxidase was found between 60 and 270 nmol/L, and the inhibition in competition with O 2 was reversible, perhaps as a result of the ability of cytochrome oxidase to metabolize NO. These results suggested that the levels of NO that inhibit the iron-sulfur centers are high in comparison with the levels of NO expected to be present in vivo. Using N-nitrosoglutathione (which decomposes to GSSG and NO with a rate of NO production of 0 to 7.6 nmol/Lϫmin Ϫ1 for concentrations of GSNO of 0 to 500 mol/L), Cleeter et al 36 demonstrated a reversible inhibition of O 2 utilization, consistent with the inhibition of complex IV. This inhibition occurred within 4 minutes after the administration of substrates. In isolated rat heart mitochondria, others showed that at nanomolar concentrations NO reversibly blocked respiration due to the inhibition of cytochrome oxidase. [37] [38] [39] This inhibition of respiration was also found in mitochondria from isolated skeletal muscle, liver, and cultured endothelial cells. 40 (1) ; the diffusion of NO (2); the concentration of NO within the cardiomyocyte and its interactions with metal ions, thiols, hemoproteins (myoglobin, Mb [3] ), and O 2 species (4); and its affinity for cytochrome oxidase (5) . In the mitochondria, NO and O 2 have a common binding site on cytochrome oxidase, and the sensitivity of mitochondrial respiration is dependent on O 2 concentration (6) . Under physiological conditions, low O 2 concentration (7) related to the gradient between the red cells and the cardiomyocyte (8) and low levels of ONOO Ϫ (9) are consistent with a reversible regulation of cardiac oxygen consumption by NO.
Production of NO
Using an amperometric NO sensor to examine the release of NO from cultured human umbilical vein endothelial cells, Tsukahara et al 41 showed that the basal release of NO by endothelial cells was 104 to 408 nmol/L. In endotheliumdenuded rings of rabbit thoracic aorta, 15 nmol/L NO produced relaxation of vascular smooth muscle. 42 The concentration of NO detected by the porphyrinic electrode on the membrane of endothelial cells was in the range of 2ϫ10 Ϫ7 to 2ϫ10 Ϫ6 mmol/L, a concentration that is 3 to 4 times higher than in cytoplasm. 43 Kelm and Schrader 44 showed that the threshold concentration of NO that induced coronary vasodilation was 1 nmol/L, and EC 50 was 7 nmol/L. eNOS is constitutively expressed in vascular endothelial cells, including capillary endothelium ( Figure 3 ). In the normal heart, eNOS is the primary NOS enzyme and is located primarily in the vascular endothelium. 45 Immunohistochemical staining has also shown a significant presence of brain NOS in the atria 46 and in perivascular nerve fibers in the myocardium of the ventricle. 47 Immunocytochemical staining studies have shown the presence of eNOS in the mitochondria isolated from rat heart. 48 This mitochondrial NOS located in the inner membrane has been shown to be constitutively expressed and active and may account for NO production to modulate mitochondrial respiration. 49 However, NO released from the vascular endothelium may be the most important source of NO in the myocardium under physiological conditions and could easily affect adjacent myocytes ( Figure 3 ).
Diffusion of NO
Taking into account the high diffusibility of NO and the close proximity of endothelial cells to myocytes, NO may have the ability to modulate the metabolic function of cardiac cells. Capillaries have the largest cross-sectional area, 100 times higher than all other vessel types combined. 50 Significant production of NO by the coronary circulation has been demonstrated both in vitro 44, 51, 52 and in vivo. 15 This release of NO may regulate cardiac metabolism, given that capillary endothelium 53 provides an abundant source of NO. The concentration of NO in tissue depends on the rate of NO synthesis; its diffusion inside the tissue; and the degradation of NO by its scavengers, oxygen free radicals and hemoproteins. Moreover, the effects of NO also depend on the prevailing O 2 tension.
The neutral charge of NO permits its rapid and wide diffusibility in tissue, without a carrier molecule to affect transport. NO diffuses in all directions from its source with a range of 150 to 300 m within 4 to 15 seconds. 54 The diffusion distance may even reach 600 m. 55 The diffusion constant of NO was calculated as 3.3ϫ10 Ϫ5 cm 2 ϫs Ϫ1 in aqueous solution at 37°C, 56 which is 1.4 times higher than the diffusion coefficient of O 2 . Taking into account the lipophilic properties of NO, the sarcolemma does not stand in the way of NO diffusion, and moreover, the cell membrane constitutes a storage reservoir for NO. eNOS is primarily a membranebound protein 57 located in the membrane subfractions called caveolae 58, 59 in a catalytically active state, bound to caveo-lin. 60 The presence of NO in the membrane may generate a gradient between the membrane and the aqueous phase on both sides of the membrane and facilitate the diffusion of NO to adjacent cells. 43 Figure 3 . A, eNOS in capillary endothelium in rat skeletal muscle. Brown staining represents the presence of eNOS. Note that there is no significant distance between the edge of the capillary and the adjoining skeletal muscle cell. Immunostaining with bovine monoclonal antibody; reproduced with permission. 13 B and C, Electron micrographs of cardiac muscle fiber (rat). Longitudinally placed myofibrils are separated by mitochondria, and a red cell is located in a capillary (B). A large pool of mitochondria is found in the vicinity of the sarcolemma (C). Endothelial cell from a capillary lies close to the sarcolemma and the mitochondria. Scale is indicated by the distance between Z lines, Ϸ2 m. The mitochondria are within the diffusion distance range of NO. NO can easily diffuse to the inner membrane of the mitochondria and regulate the function of the following mitochondrial enzymes: complexes I and II, aconitase, and especially cytochrome c oxidase.
NO reacts with O 2 species, metal ions, thiols, and hemoproteins, ie, hemoglobin and cytochrome c, which are present in the microenvironment of the endothelial cell. These factors could decrease the half-life of NO, its diffusion distance, and consequently its biological activity. 61 In rabbit thoracic aortic rings, Malinski et al 56 reported the in situ measurements of NO release from a single endothelial cell and its subsequent diffusion to the smooth muscle cells with a sensor placed at a distance of 100Ϯ2 m from the endothelial layer. Bradykinin (10 nmol) injected in the proximity of the sensor placed on the endothelial cell membrane produced a measurable amount of NO after 100Ϯ25 ms, and the maximum concentration of NO (1.3Ϯ0.05 mol/L) was recorded after 13.3Ϯ0.1 seconds. In the muscle, detection of NO was recorded after 3.0Ϯ0.2 ms, and a maximum NO concentration of 0.85 mol/L was observed 20.2Ϯ0.1 seconds after the injection of bradykinin. Malinski et al 56 also showed that the concentration of NO was the same on both sides of the cell (luminal and abluminal sides). They observed a time delay of 1.5 seconds between the theoretical and experimental concentration of NO at 100 mol/L from endothelial cell, indicating that Ϸ37% of NO was consumed. They emphasized that this consumption of NO in the tissues requires a steep concentration gradient to keep the NO supply by the diffusion process effective. After stimulation, they detected a maximum concentration of NO on the cell surface of 1.02Ϯ0.08 mol/L after 12.4Ϯ0.1 seconds and a concentration of NO in the middle of the endothelial cell that was lower by 60Ϯ25% during the first 500 to 800 ms. Those data are consistent with the hypothesis that the cell membrane can develop a relatively high concentration of NO within a short period of time and participate in the creation of a gradient between the endothelial cell and the aqueous cytoplasm and extracellular fluid. This gradient facilitates the diffusion of NO to the muscle cell.
The presence of biological membranes in the cells may, on the other hand, partially limit the activity of NO. Liu et al 62 showed that disappearance of NO in aqueous solution was accelerated by the presence of hydrophobic phases, in which 90% of the NO reaction with O 2 occurs. Mitochondria may participate in the NO oxidation by this mechanism and may be important sites for the metabolism of NO and the formation of NO-derived reactive species. Recently, Zai et al 63 suggested that the entry of NO into the cell from the extracellular medium could be facilitated by a transnitrosation mechanism, catalyzed by the cell-surface protein disulfide isomerase (PDI), a protein that catalyzes thiodisulfide exchange reactions. PDI contributes to 0.025% of the cellsurface thiol population. Reduction of expression of PDI, using antisense, leads to a reduction of the thiol pool on the surface of the cell and to modification in access of extracellular NO to the cytoplasm.
Poderoso et al, 39 taking into account the myoglobin concentration and the fact that a significant portion of endothelial NO could be trapped by myoglobin, argued that the steadystate NO concentration in myocytes should be in the range of 0.1 to 0.3 mol/L. Malinski et al 64 measured the local concentration of NO in cerebral tissue during and after transient middle cerebral artery occlusion in the rat. The basal NO concentration was below the detection limit of the sensor (10 Ϫ8 mol/L), but on initiation of ischemia NO increased to 10 Ϫ6 mol/L. Thus, at the concentration range of NO observed and expected in vivo, cytochrome oxidase is a likely target for NO regulation of mitochondrial respiration.
Effects of PO 2
Several studies suggest that the effect of NO depends on O 2 concentration, respiration state, and availability of substrate. Schweizer and Richter 65 showed that, at an O 2 tension similar to that found in venous blood (Ϸ35 mm Hg), micromolar concentrations of NO induced a rapid and complete but reversible de-energization of mitochondria. Takehara et al 66 also demonstrated that in liver mitochondria NO reversibly inhibited mitochondrial respiration in a dose-and O 2 concentration-dependent manner. The inhibition occurred at physiologically low O 2 concentrations. Borutaite and Brown 37 showed that the sensitivity of respiration to NO (1 mol/L) depended on the O 2 concentration and also on substrate type and respiration rate in rat heart mitochondria. The inhibition of O 2 respiration rate was greater at 52 to 65 mol/L O 2 than at 126 to 168 mol/L O 2 . Respiration was more sensitive to NO with pyruvate than with succinate. The sensitivity of respiration rate to NO was lower in state 4 than in state 3; this may be due to the extent of control of the coefficient of cytochrome oxidase over mitochondrial respiration in state 3. 67 Torres et al 68 showed that the onset of inhibition of cytochrome c oxidase by NO occurred in Ͻ15 seconds. This inhibition occurred in competition with O 2 and was more effective at low O 2 concentrations. Clementi et al 69 studied the rate of O 2 consumption of porcine aortic endothelial cell suspension with glucose in a gas-tight vessel equipped with electrodes to detect O 2 and NO. Cell respiration was analyzed with O 2 concentrations decreasing from 100 to 0 mol/L. These experiments showed that the rate of O 2 consumption varied with its concentration and suggest that endogenous production of NO plays a role in this mechanism by lowering the affinity of cytochrome oxidase for O 2 . At low levels of NO, the inhibition of cytochrome oxidase is reversible and competitive with that of O 2 , but at high levels and long-term exposure (24 hours), the inhibition of mitochondrial aconitase and of complexes I and II appears to be irreversible. Halfmaximal inhibition of respiration occurred at 9.8Ϯ1.0 mol/L O 2 . Addition of an eNOS inhibitor or the NO scavenger hemoglobin caused an increase in O 2 consumption. Bradykinin, which increases the production of NO by endothelial cells, induced a transient decrease in O 2 consumption. The concentration of NO produced was independent of the O 2 concentration, but the importance of the inhibition of respiration was dependent on the concentration of O 2 (33.9Ϯ2.3% and 58.1Ϯ2.7% at 80 and 40 mol/L O 2 , respectively). To demonstrate that the inhibition of respiration was dependent on cytochrome c oxidase, the same experiments were conducted with an inhibitor of mitochondrial complex III, whereas cell respiration was maintained via cytochrome oxidase alone, using an electron donor and ascorbic acid as a primary reducing agent. Administration of bradykinin elicited a release of NO that inhibited mitochondrial respiration in the same way as the inhibition occurring in cells respiring on glucose. Under the same conditions, N -nitro-L-arginine methyl ester (L-NAME) increased O 2 consumption. It is also important to note that the half-life of NO is increased during the decrease in PO 2 . 70
PO 2 in Tissues
Taking into account the O 2 dependence of mitochondrial respiration, it is important to consider whether O 2 and NO concentrations match, to support a potential physiological role for NO in the regulation of mitochondrial respiration. At normal cardiac myocardial oxygen consumption (MV O 2 ), the mean capillary PO 2 is equal to the coronary venous PO 2 (Ϸ20 torr). The factors that control O 2 availability in cardiomyocytes include the following (1) O 2 delivery from the red cells, (2) the diffusion distance for O 2 (Ϸ2 m to reach the sarcolemma and 13 m to reach the center of the cell), (3) the blood flow, (4) the transmural distribution of the blood flow, and (5) the PO 2 gradient from the blood vessel to the myocyte. From the capillaries to the cytosol, O 2 is transported passively by diffusion. 71 The diffusion equation for O 2 in peripheral tissue is dependent on the capillary surface area and is inversely related to the squared distance from the capillaries to the mitochondria. A unit of capillary lumen surface supplies 3 to 5 units of sarcolemma area, 50 to 200 units of mitochondrial surface, and up to 600 units of mitochondrial inner membrane. 72 Moreover, the functional area of capillaries for O 2 , determined by the density of red cells, is smaller. 73 Myoglobin in the myocardium binds O 2 reversibly and is responsible for the oxygenation of the cytosol. Myoglobin facilitates O 2 diffusion and uniform oxygenation in heart cells and maintains an O 2 -free environment within the cell. O 2 delivery to mitochondria occurs through dissolved O 2 and the diffusion flux caused by oxymyoglobin. Heterogeneities of muscle fiber dimensions are of minor importance for muscle O 2 supply, as they are compensated by the high myoglobin-facilitated O 2 diffusivity inside the muscle cell. 74 Myoglobin-dependent O 2 uptake is proportional to the fraction of sarcoplasmic myoglobin combined with O 2 , and myoglobin-mediated O 2 delivery to mitochondria may contribute importantly to the ability of the heart to sustain maximum work output. 75 Wittenberg and Wittenberg 76 calculated the sarcoplasmic free O 2 concentration to be Ϸ3.2 mol at 37°C, and the ratio of myoglobin-bound O 2 to free O 2 , 30:1. Gayeski and Honig 77 demonstrated in the subepicardium that PO 2 in equilibrium with myoglobin was remarkably uniform among 5 different species, Ϸ4.3 to 7.0 torr. These values were consistent with the values obtained by other techniques. 78 Gayeski and Honig 77 demonstrated that minimum myoglobin saturation was 32% in dogs and myoglobin saturation and PO 2 in equilibrium with myoglobin appeared remarkably uniform, even though arterial PO 2 ranged between 83 and 326 torr.
Thus, the myocardium has an extremely low PO 2 under physiological conditions. The main determinant of this low PO 2 in tissue is related to the extracellular and intracellular gradient of O 2 . Extracellular gradient is the difference of PO 2 between the surface of the red cell in the capillaries and the sarcolemma and is considered to be Ϸ15 torr for a distance of 2 m from the capillary lumen to sarcolemma. This gradient can be explained by the absence of a carrier in the extracellular space (peri-erythrocyte plasma, capillary endothelium, and interstitial space 79 ), a non-uniform unloading of red blood cells, 74 and the discrepancy between capillary surface area and cardiomyocyte sarcolemma area. Moreover, the distribution of the mitochondria may not be homogeneous among cells, and some populations of mitochondria are located in juxtacapillary areas (Figure 3 ). The mitochondrial system could be considered as a syncytial network, and this network may influence O 2 pathway and may imply less of a role for myoglobin in intracellular transport. 80 There are still a number of controversies concerning the intracellular gradient of O 2 that may affect cellular energetics and cellular function. [81] [82] [83] [84] [85] [86] Demonstrating a low intracellular gradient in isolated cardiac cells, 83 it was found that the O 2 dependence of respiration by mitochondria isolated from cardiac cells was a function of the energy state and substrate availability and that the O 2 dependence of mitochondrial respiration in situ was dependent on both cellular metabolic state and on the O 2 concentration difference between extracellular media and the mitochondria. In this model, in cells, the region of O 2 dependence began at Ϸ20 mol/L (ϭ14 torr). They concluded that for actively working cells in situ, the dominant factors are those that affect the delivery of O 2 to the tissue, ie, blood oxygenation, coronary flow, and functional capillary surface area. Kreutzer and Jue 84 found that above an intracellular PO 2 of 4 mm Hg, the myocyte is sufficiently oxygenated and shows neither physiological nor biochemical signs of hypoxia. This critical level of PO 2 was consistent with other studies showing PO 2 values between 8 and 14 mm Hg. 87 Takahashi et al 88 hypothesized that the gradient in the center of the cell might account in part for the suppression of mitochondrial respiration caused by insufficient diffusional O 2 delivery. They concluded that whereas with nonlimiting O 2 supply, mitochondrial O 2 consumption is principally set by the energy state, at increased cellular O 2 demand the center of the cell is more sensitive to hypoxia because of the limitation of O 2 diffusion.
Thus, the level of PO 2 in the myocyte is assumed to be very low, and the gradient between HbO 2 in red cells and the sarcolemma may be most important. The levels of PO 2 in cardiac cells and near the mitochondria and the concentration of NO in tissue and its diffusion are consistent with a role of NO in the regulation of mitochondrial respiration. Furthermore, molecular O 2 has itself a direct regulatory effect on cytochrome c oxidase, ie, a reversible inhibition of cellular respiration in the presence of low PO 2 , which could allow cells to adapt their respiratory rate to the ambient PO 2 in tissue. 89
Toxicity of NO Depends on O 2 Concentration
The toxicity of NO is mainly determined by its interaction with O 2
Ϫ and should increase with increased PO 2 in tissue. Ioannidis et al 90 Ϫ and/or H 2 O 2 was discussed, but the low levels of production of H 2 O 2 during these experiments and its rapid degradation by catalase and glutathione peroxidase seemed to have no additive effect on toxicity. Under these conditions, the production of O 2 Ϫ and ONOO Ϫ was unlikely to reach toxic levels. These results are of great importance because under physiological concentrations of O 2 , NO can exert its regulatory function without cytotoxicity. In these experiments, the amount of NO produced reaches micromolar concentrations, yet the physiological level of NO concentration in tissue ranges from 100 to 500 nmol/L at baseline. Even micromolar concentrations of NO do not seem to have cytotoxic effects as described by Ioannidis et al. 90 
Role of NO Species in the Control of Oxygen Consumption
NO binds to cytochrome c oxidase, and this is a main mechanism for inhibition of mitochondrial respiration. But the effects on mitochondrial respiration could also be related in part to the production of superoxide (O 2 Ϫ ) and other NO species, such as peroxynitrite (ONOO Ϫ ). 91 Reaction of NO with O 2 Ϫ produces ONOO Ϫ , which reacts with all major classes of molecules and can cause toxicity independent of NO or O 2 Ϫ . 92 Activated macrophages produce a significant amount of ONOO Ϫ , and ONOO Ϫ has been shown to inhibit cellular respiration. [93] [94] [95] The inhibition of mitochondrial respiration therefore could be due to either NO or ONOO Ϫ . In the heart, in vitro, Xie et al 96 demonstrated that NO, produced by a NO donor (SNAP) or through endogenous NO release (bradykinin or carbachol), suppressed mitochondrial respiration, and endogenous ONOO Ϫ formation was not necessary. Tiron, an intracellular scavenger of O 2 Ϫ , or uric acid, a scavenger of ONOO Ϫ , did not modify the effects of SNAP. The effect of NO on respiration was completely reversible. Ϫ promotes enhanced suppression of respiration that is no longer rapidly reversed. Using a theoretical mathematical model, Kelm and Schrader 51 showed that ONOO Ϫ is not formed in significant amounts until Ͼ90% of oxyhemoglobin is consumed. These data suggest that, in the presence of oxyhemoglobin maintaining a low level of NO, there is very little ONOO Ϫ formation in the presence of micromolar amounts of both proteins. 61 ONOO Ϫ has little or no effect on cytochrome c oxidase but inhibits mitochondrial respiration at complexes I to III and II to III 93 and is probably the original mechanism resulting in macrophage toxicity, given that macrophages make both NO and O 2 Ϫ . 36 Lizasoain et al 97 showed that the direct effect of NO was on complex IV with an IC 50 of 2 mol/L. They showed that ONOO Ϫ persistently inhibited respiration at complexes I to III and II to III without affecting complex IV. They also suggested that ONOO Ϫ , through its interaction with glucose or reduced glutathione, could also generate NO donors and thus had indirect effects on mitochondrial respiration.
Regulation of O 2 Consumption In Vivo
NO produced by the capillary endothelium can diffuse to the underlying myocytes to regulate O 2 consumption by mitochondria 98 by altering the affinity of O 2 for cytochrome c. Photomicrographs supporting the spatial relationships needed to support this hypothesis are shown in Figures 3B and 3C .
In vivo, Shen et al 17 showed that inhibition of NO synthesis increased total-body O 2 consumption and increased body temperature. This was due, in large part, to an increase in O 2 extraction because cardiac output fell. Furthermore, the increase in O 2 extraction was not due to the vasoconstriction, because infusion of another vasoconstrictor did not increase O 2 consumption to a similar degree. King et al 16 showed that NOS inhibition significantly elevated skeletal muscle O 2 uptake. Bernstein et al 15 showed that O 2 consumption in the heart was increased at any level of cardiac work after inhibition of NOS. This was due again to a change in myocardial O 2 extraction, given that there was a downward shift in the MV O 2 -coronary sinus PO 2 relationship. In the skeletal muscle circulation of the conscious dog at rest and during exercise, inhibition of NO synthesis also increased O 2 consumption at all levels of external work, 18 independent of the change in skeletal muscle blood flow. 99 Loke et al 100 observed that bovine polymerized hemoglobin-based O 2 carrying solution doubled O 2 consumption by the heart in conscious dogs as a result of increased extraction. Angiotensin II administration induced a similar effect on vascular resistance, but the increase in V O 2 was smaller (31%Ϯ12 versus 78%Ϯ17%). These results are consistent with the scavenging properties of hemoglobin-based O 2 carrying on NO. 101 Recchia et al 102 reported that an acute inhibition of NO synthesis using N-nitro-L-arginine increased O 2 consumption in normal conscious dogs. This was associated with an acute change in cardiac substrate utilization similar to that observed during cardiac decompensation. The MV O 2 changes and substrate utilization could be rapidly reversed after administration of a NO donor. These findings were confirmed in another study, in which the increase of MV O 2 with blockade of NO synthesis could be underestimated by the change in substrate utilization, the reduction of myocardial free fatty acid utilization and the increase in carbohydrate (lactate and glucose) utilization. Switching from free fatty acid to lactate can result in a reduction of O 2 consumption, because lactate is a more efficient fuel and may account for a Ϸ10% reduction of MV O 2 . 103, 104 In conscious dogs, the stimulation of free fatty acid uptake by lipid infusion caused an exaggerated increase in cardiac O 2 consumption in combination with nitro-L-arginine administration. 105 In conscious dogs, NO can also play a major role in maintaining a balance between O 2 consumption and sodium reabsorption, the major ATP-consuming process in kidney, and NO can inhibit mitochondrial O 2 consumption in canine renal slices as well. 106 
Regulation of O 2 Consumption In Vitro
In isolated rat heart perfused with solutions of increasing concentrations of NO, Poderoso et al 39 showed a dosedependent decrease in myocardial O 2 uptake. The decrease in myocardial O 2 uptake was related mostly to the inhibition of cytochrome oxidase. Half-inhibition of heart mitochondrial state 3 respiration was achieved at Ϸ0.4 mol/L NO. These results were consistent with previous studies from the same group that showed a half-maximal inhibition of cytochrome oxidase at Ϸ0.1 mol/L NO in rat heart mitochondria. 107 In in vitro experiments, Shen et al 108 showed that the release of NO from skeletal muscle by bradykinin or acetylcholine, or due to the chemical release of NO by SNAP, led to a reduction in skeletal muscle O 2 consumption. In addition, the mechanism of action of NO in those studies appears to be through a cGMP-independent, direct action of NO on mitochondrial metabolism. In normal myocardial muscle isolated from the left ventricular free wall of dogs, Xie et al 98 showed that endogenous, endothelium-derived NO can attenuate mitochondrial respiration of adjacent myocytes. The inhibitory effects of bradykinin and carbachol, but not of SNAP, were prevented by N -nitro-L-arginine. Loke et al 109 demonstrated that bradykinin loses its ability to reduce O 2 consumption in myocardial tissues taken from eNOS-deficient mice ( Figure  4 ), but the response was still present in hearts of iNOSdeficient mice. Moreover, Pittis et al 110 showed (Figure 4 ) that the coincubation of normal coronary microvessels with cardiac tissue isolated from mice lacking eNOS or stimulation of coronary microvascular eNOS by bradykinin produce enough NO to regulate MV O 2 . These studies emphasize the pivotal role of eNOS as a source of NO to regulate parenchymal cell O 2 consumption. This regulatory effect of NO through bradykinin, ramiprilat, amlodipine or derived from exogenous sources (SNAP) also occurred in the nonhuman primate heart. Coronary microvessels isolated from the left ventricle of the primate heart released nitrite in response to the same drugs, supporting the importance of the coronary microvasculature as a potential source of NO. 111 Other studies, conducted in the in situ heart of anesthetized open-chest dogs 112 or pigs 113 or in the sedated canine 114 have produced conflicting results. This discrepancy could perhaps be explained by the presence of anesthetic drugs, some of which interfere with cellular respiration at the same site as NO. 115 Moreover, the switch in substrate utilization related to NO synthesis blockade, as mentioned above (ie, more efficient fuel), could minimize the increase of O 2 consumption, and this may be another explanation for the differences in the studies of the regulation of myocardial O 2 consumption by NO in whole animals.
Changes in the Modulation of Oxygen Consumption by NO in Heart Failure or Diabetes
In heart failure and diabetes, NO production by blood vessels is reduced or abolished. 116 -120 NO-dependent coronary vasodilation is impaired in conscious dogs after the development of pacing-induced heart failure or alloxan-induced diabetes. 5, 121 Recchia et al 101 showed that the transition to decompensated heart failure is associated with a fall of cardiac NO production and a shift in cardiac substrate utilization. After the development of severe dilated cardiomyopathy and heart failure, the NO-dependent component of both shear stress and agonist-induced arteriolar dilation was also reduced or abolished. 122 In tissues from dogs after heart failure 98, 123 and diabetes, 124 the inhibitory effect of endogenous NO on the consumption of O 2 is attenuated. The depressed modulation of O 2 consumption in tissue was not related to mitochondrial dysfunction or structural changes in mitochondria, because a NO donor still exerts an inhibitory effect on O 2 consumption after pacing-induced heart failure or diabetes. The decreased Bradykinin had no effect on oxygen consumption in canine microvessels and no effect in eNOS Ϫ/Ϫ mouse heart. Coincubation of microvessels (that can release NO) with mouse heart (that cannot release NO to bradykinin but can respond to NO) results in a significant reduction in oxygen consumption. These data indicate that microvessels can transfer NO to tissue over some diffusion distance to control mitochondrial function and tissue oxygen consumption. #PϽ0.05 vs 0.
release of NO from the vascular endothelium contributes to the depressed modulation of O 2 consumption by endogenous NO after heart failure and diabetes. However, in the failing human heart, the modulation of O 2 consumption by both endogenous NO, using agents that stimulate endogenous NO release, and exogenous NO, through NO-releasing compounds, was partially preserved. 125
Conclusion
Because the content of O 2 in the early atmosphere was low and the NO concentration higher than today, NO was probably a substrate for early prokaryote life forms. 126, 127 As suggested by Castresana and Saraste, 128 the cytochrome oxidase of the earliest universal ancestor might have metabolized NO rather than O 2 . NO reductase, the primary enzyme implicated in denitrification, ie, an anaerobic respiratory process that reduces nitrate to dinitrogen (N 2 ) via nitrite, NO, and nitrous oxide, 129 has strong homology to cytochrome oxidase. The phylogeny of subunit I of cytochrome oxidase and the first unit of NO reductase suggests that the first oxidase may have evolved from NO reductase and that denitrification preceded aerobic respiration. The increasing concentration of O 2 in the earth's atmosphere caused by oxygenic photosynthesis of cyanobacteria probably led to the substitution of iron for copper in the ancestral oxidase to reduce O 2 more efficiently. 130, 131 This occurred in combination with changes in the protein environment around the catalytic site and the evolution of proton channels. Several characteristics suggest that mitochondria descend from prokaryotes, ie, size, the presence of circular DNA, and independent enzymatic complexes (ribosomes) that are of the bacterial type. Hence, early eukaryotes probably acquired aerobic respiration when the atmospheric levels of O 2 increased, by a symbiotic process between bacteria and eukaryotes some 1.5 billion years ago. NO regulation of mitochondrial function and its physiological role in mammals may be related to this evolutionary process.
